I’m a Freelancer: Here’s Why I Prefer To Get Paid in Crypto
While cryptocurrency is a volatile investment, this freelancer prefers it to fiat currency when getting paid. Here's how stablecoins improve his financial life.
Wendy’s (NASDAQ:WEN) Q1 Earnings Results: Revenue In Line With Expectations
Fast-food chain Wendy’s (NASDAQ:WEN) met Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 2.1% year on year to $523.5 million. Its non-GAAP profit of $0.20 per share was in line with analysts’ consensus estimates.
Environmental groups blast JBS's US listing approval; Wall Street praises it
SAO PAULO (Reuters) -The U.S. financial regulator's approval last month of a proposal by the world's largest meatpacker JBS to list on the New York Stock Exchange is drawing strong criticism from climate and animal rights groups but praise from Wall Street. In multiple statements after April 22, when Brazil's JBS said the U.S. Securities and Exchange Commission (SEC) greenlit its dual-listing plan to broaden its investor pool and raise its valuation closer to peers, environment activists and animal rights lobbies have unleashed a campaign condemning it. They cited sprawling criminal investigations into JBS or its controllers in Brazil and in the U.S., as well as concerns over the deforestation of the Amazon and the company's outsized role as a large global emitter of greenhouse gases in the course of its operations.
Profits at American oil giants Exxon Mobil and Chevron fall in tandem with waning energy demand
The oil and gas giant earned $7.71 billion, or $1.76 per share, for the three months ended March 31. The results topped Wall Street expectations, but Exxon does not adjust its reported results based on one-time events such as asset sales. Analysts polled by Zacks Investment Research expected earnings of $1.74 per share.
Terex (NYSE:TEX) Reports Sales Below Analyst Estimates In Q1 Earnings, But Stock Soars 5.8%
Lifting and material handling equipment company Terex (NYSE:TEX) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 4.9% year on year to $1.23 billion. On the other hand, the company’s full-year revenue guidance of $5.4 billion at the midpoint came in 2.2% above analysts’ estimates. Its GAAP profit of $0.31 per share was 29.7% below analysts’ consensus estimates.
Wall Street climbs on tariff optimism, strong jobs data
Wall Street's main indexes advanced on Friday, as signs of a de-escalation in the trade war with China and a strong jobs report calmed concerns around the economic toll of tariffs. Beijing said on Friday it was "evaluating" an offer from Washington to hold talks over U.S. President Donald Trump's 145% tariffs on China. The tit-for-tat tariffs between the world's two largest economies have kept investors on edge, with both sides unwilling to be seen backing down in a trade war that has roiled global markets.
Exxon beats Wall Street profit estimate, on track to meet buyback target
HOUSTON (Reuters) -Exxon Mobil on Friday beat Wall Street's estimate for first-quarter profit as higher oil and gas production from Guyana and the Permian basin helped boost earnings. The buyback figure puts Exxon on track to meet its annual share repurchase goal of $20 billion. The energy sector has faced a tumultuous start to the year after U.S. President Donald Trump's global tariff announcements stoked recession fears.
Damn the torpedoes! Stocks go full speed ahead despite declining U.S. shipping and manufacturing data
Buying momentum continued in Asia and European stock markets today, and S&P futures were priced up this morning.
Amneal (NASDAQ:AMRX) Misses Q1 Sales Targets, Stock Drops 11.3%
Pharmaceutical company Amneal Pharmaceuticals (NASDAQ:AMRX) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 5.5% year on year to $695.4 million. On the other hand, the company’s full-year revenue guidance of $3.05 billion at the midpoint came in 0.8% above analysts’ estimates. Its non-GAAP profit of $0.21 per share was 43.2% above analysts’ consensus estimates.